Code intelligence

Z12.31 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code Z12.31.

Elevated code riskView ICD-10 detail

Signal breakdown

5 shown · 5 total in platform

Risk: Elevated
0

Critical

0%

4

High

80%

1

Routine

20%

0

Low

0%

New this month

alerts added in last 30 days

Effective soon

no upcoming deadlines

LCD L33950: Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography — CGS

Policy LCD-L33950 · Radiology

High

Prepare for new breast imaging billing guidelines in 2025.

Proposed LCD DL40222: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer — Noridian

Policy LCD-DL40222 · Oncology

High

Impact on billing for targeted molecular panel tests.

LCD L37824: MolDX: Breast Cancer Index® (BCI) Gene Expression Test — Noridian

Policy LCD-L37824 · Oncology

Routine

New BCI test to impact oncology billing from July 2025.

Proposed LCD DL40144: MolDX: Biomarker Testing for Risk Stratification in DCIS — Noridian

Policy LCD-DL40144 · Oncology

High

Impact of new MolDX LCD on DCIS biomarker testing billing.

Proposed LCD DL40142: MolDX: Biomarker Testing for Risk Stratification in DCIS — Palmetto GBA

Policy LCD-DL40142 · Oncology

High

New LCD for DCIS testing may impact billing practices.

Audit documentation

Building an audit file that includes Z12.31?

The Tripwire Audit Pack exports 12 months of Radiology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Radiology audit pack — $349One-time purchase · not a subscription